|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | |
| A61K 39/395 |
| (11) | Patento numeris | 2437791 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10783933.4 |
| Europos patento paraiškos padavimo data | 2010-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/036923 |
| Data | 2010-06-01 |
| (87) | Numeris | WO 2010/141483 |
| Data | 2010-12-09 |
| (30) | Numeris | Data | Šalis |
| 182928 P | 2009-06-01 | US |
| (72) |
ZHU, Fu-Gang, US
KANDIMALLA, Ekambar, R., US
AGRAWAL, Sudhir, US
|
| (73) |
Idera Pharmaceuticals, Inc.,
167 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | POTENTIATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE TREATMENTS BY IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) ANTAGONISTS OF TLR7 AND TLR9 |
| POTENTIATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE TREATMENTS BY IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) ANTAGONISTS OF TLR7 AND TLR9 |